Qiu-Xu Teng - Search Results

Year	Number of Results
2018	2
2019	3
2020	18
2021	11
2022	7
2023	5
2024	2

1

Signaling pathways and therapeutic interventions in gastric cancer.

Lei ZN, Teng QX, Tian Q, Chen W, Xie Y, Wu K, Zeng Q, Zeng L, Pan Y, Chen ZS, He Y. Lei ZN, et al. Among authors: teng qx. Signal Transduct Target Ther. 2022 Oct 8;7(1):358. doi: 10.1038/s41392-022-01190-w. Signal Transduct Target Ther. 2022. PMID: 36209270 Free PMC article. Review.

2

Revisiting mTOR inhibitors as anticancer agents.

Teng QX, Ashar YV, Gupta P, Gadee E, Fan YF, Reznik SE, Wurpel JND, Chen ZS. Teng QX, et al. Drug Discov Today. 2019 Oct;24(10):2086-2095. doi: 10.1016/j.drudis.2019.05.030. Epub 2019 Jun 4. Drug Discov Today. 2019. PMID: 31173912 Review.

3

Understanding and targeting resistance mechanisms in cancer.

Lei ZN, Tian Q, Teng QX, Wurpel JND, Zeng L, Pan Y, Chen ZS. Lei ZN, et al. Among authors: teng qx. MedComm (2020). 2023 May 22;4(3):e265. doi: 10.1002/mco2.265. eCollection 2023 Jun. MedComm (2020). 2023. PMID: 37229486 Free PMC article. Review.

4

ATP-binding cassette (ABC) transporters in cancer: A review of recent updates.

Wang JQ, Wu ZX, Yang Y, Teng QX, Li YD, Lei ZN, Jani KA, Kaushal N, Chen ZS. Wang JQ, et al. Among authors: teng qx. J Evid Based Med. 2021 Sep;14(3):232-256. doi: 10.1111/jebm.12434. Epub 2021 Aug 13. J Evid Based Med. 2021. PMID: 34388310 Review.

5

Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance.

Wang JQ, Yang Y, Cai CY, Teng QX, Cui Q, Lin J, Assaraf YG, Chen ZS. Wang JQ, et al. Among authors: teng qx. Drug Resist Updat. 2021 Jan;54:100743. doi: 10.1016/j.drup.2021.100743. Epub 2021 Jan 13. Drug Resist Updat. 2021. PMID: 33513557 Review.

6

ABCB1-dependent collateral sensitivity of multidrug-resistant colorectal cancer cells to the survivin inhibitor MX106-4C.

Lei ZN, Albadari N, Teng QX, Rahman H, Wang JQ, Wu Z, Ma D, Ambudkar SV, Wurpel JND, Pan Y, Li W, Chen ZS. Lei ZN, et al. Among authors: teng qx. Drug Resist Updat. 2024 Mar;73:101065. doi: 10.1016/j.drup.2024.101065. Epub 2024 Feb 6. Drug Resist Updat. 2024. PMID: 38367548

7

Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitor.

Teng QX, Lei ZN, Wang JQ, Yang Y, Wu ZX, Acharekar ND, Zhang W, Yoganathan S, Pan Y, Wurpel J, Chen ZS, Fang S. Teng QX, et al. Drug Resist Updat. 2024 Mar;73:101028. doi: 10.1016/j.drup.2023.101028. Epub 2023 Nov 29. Drug Resist Updat. 2024. PMID: 38340425

8

Antimicrobial Peptide Reverses ABCB1-Mediated Chemotherapeutic Drug Resistance.

Luo X, Teng QX, Dong JY, Yang DH, Wang M, Dessie W, Qin JJ, Lei ZN, Wang JQ, Qin Z, Chen ZS. Luo X, et al. Among authors: teng qx. Front Pharmacol. 2020 Aug 7;11:1208. doi: 10.3389/fphar.2020.01208. eCollection 2020. Front Pharmacol. 2020. PMID: 32903706 Free PMC article.

9

Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells.

Wu ZX, Teng QX, Cai CY, Wang JQ, Lei ZN, Yang Y, Fan YF, Zhang JY, Li J, Chen ZS. Wu ZX, et al. Among authors: teng qx. Biochem Pharmacol. 2019 Aug;166:120-127. doi: 10.1016/j.bcp.2019.05.015. Epub 2019 May 9. Biochem Pharmacol. 2019. PMID: 31078601

10

Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells.

Feng W, Zhang M, Wu ZX, Wang JQ, Dong XD, Yang Y, Teng QX, Chen XY, Cui Q, Yang DH. Feng W, et al. Among authors: teng qx. Front Oncol. 2020 Jun 25;10:955. doi: 10.3389/fonc.2020.00955. eCollection 2020. Front Oncol. 2020. PMID: 32670878 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

46 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year